GlobeNewsWire
06 Aug 2026, 12:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Outlook Therapeutics will report its Q3 FY2026 financial results and host a corporate update on August 14, 2026. — Earnings reports and corporate updates are primary catalysts for stock price volatility in small-cap biotech companies.
+0.30Which stocks this story touches
The article is a routine announcement regarding upcoming financial results and corporate updates.
Continue reading
6 related stories
Top 2 movers · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
53m ago
